First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
Patnaik, A., Appleman, L.J., Tolcher, A.W., Papadopoulos, K.P., Beeram, M., Rasco, D.W., Weiss, G.J., Sachdev, J.C., Chadha, M., Fulk, M., Ejadi, S., Mountz, J.M., Lotze, M.T., Toledo, F.G.S., Chu, E., Jeffers, M., Peña, C., Xia, C., Reif, S., Genvresse, I., Ramanathan, R.K.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling
Beeram, M, Tan, Q-TN, Tekmal, RR, Russell, D, Middleton, A, deGraffenried, LA
Published in Annals of oncology (01.08.2007)
Published in Annals of oncology (01.08.2007)
Get full text
Journal Article
329 A first-in-human study evaluating the safety and pharmacology of MM-151, a novel oligoclonal anti-EGFR antibody combination in patients with refractory solid tumors
Beeram, M, Lieu, C, Harb, W, Power, L, Kearns, J, Nering, R, Moyo, V, Wolf, B, Adjei, A
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
96 Evaluation of hormone therapies in a panel of breast PDX models: Relevance of ER status on sensitivity to letrozole and tamoxifen
Wick, M.J, Vaught, T, Gamez, L, Meade, J, Diaz, A, Papadopoulos, K.P, Rasco, D.W, Patnaik, A, Beeram, M, Lang, A, Tolcher, A.W
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
56 Establishment, Characterization and Evaluation of a Panel of Patient-derived Low Passage Breast Tumor Models
Wick, M, Vaught, T, Kelly, S, Farley, M, Tolcher, A, Rosenthal, A, Rodriguez, L, Beeram, M, Lang, A, Papadopoulos, K
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
413 Phase II study evaluating the efficacy, safety and pharmacodynamic correlative study of dual anti-angiogenic inhibition using Bevacizumab (B) in combination with Sorafenib (S) in patients (pts) with advanced malignant melanoma
Mahalingam, D, Beeram, M, Rodon, J, Sankhala, K, Mita, A, Benjamin, D, Michalek, J, Tolcher, A, Wright, J, Sarantopoulos, J
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
372 A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors
Weekes, C, Hedge, P, Xin, Y, Yu, R, Xiang, H, Gore, L, Beeram, M, Brachmann, R, Patnaik, A
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
395 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with erlotinib: clinical and preclinical experience
Patnaik, A, Besterman, J, Tolcher, A.W, Mehran, M, Drouin, M, Maroun, C, Bonfils, C, Beeram, M, Martell, R, Papadopoulos, K
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
396 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with docetaxel: clinical and preclinical experience
O'Dwyer, P, Papadopoulos, K, Amaravadi, R, Harlacker, K, Beeram, M, Drouin, M, Mehran, M, Besterman, J, Maroun, C, Patnaik, A
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Identification and molecular characterization of invasive lobular breast cancer models in a panel of 180 breast XPDX models
Flores, J., Moriarty, A., Lizette, F., Lang, A., Rosenthal, A., Papadopoulos, K., Beeram, M., Patnaik, A., Rasco, D., DeBerry, B., Elmi, M., Drengler, R., Hernandez, T., Sharma, M., Lakhani, N., Smith, L., Moreno, V., Calvo, E., Garcia-Foncillas, J., Wick, M.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
383MO Imlunestrant with or without everolimus or alpelisib, in ER+, HER2- advanced breast cancer (aBC): Results from the phase Ia/b EMBER study
Jhaveri, K., Jeselsohn, R., Ma, C.X., Lim, E., Yonemori, K., Hamilton, E.P., Harnden, K., Im, S-A., Beck, T., Sammons, S., Bhave, M., Kaufman, P.A., Manich, C. Saura, Meniawy, T., Bacchion, F., Ismail-Khan, R., Li, Y., Estrem, S.T., Nguyen, B., Beeram, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Raf: A Strategic Target for Therapeutic Development Against Cancer
BEERAM, Muralidhar, PATNALK, Amita, ROWINSKY, Eric K
Published in Journal of clinical oncology (20.09.2005)
Published in Journal of clinical oncology (20.09.2005)
Get full text
Journal Article
209P Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors
Klempner, S.J., Beeram, M., Sabanathan, D., Chan, A., Hamilton, E., Loi, S., Oh, D-Y., Emens, L.A., Patnaik, A., Kim, J.E., Park, Y.H., Odegard, V., Hamke, S., Jang, G., Jacquemont, C., Hunder, N., Piha-Paul, S.A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
2118 POSTER A phase I study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer
Krop, I.E, Beeram, M, Modi, S, Rabbee, N, Girish, S, Tibbitts, J, Holden, S.N, Lutzker, S.G, Burris, H.A
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
7004 ORAL Phase II randomized, placebo controlled study of sorafenib in combination with dacarbazine in subjects with unresectable Stage III or Stage IV melanoma
McDermott, D, Sosman, J.A, Hodi, F.S, Gonzalez, R, Linette, G, Richards, J, Jakub, J.K, Beeram, M, Patel, K, Hersch, E
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Biomarker and clinical activity of CPI-444, a novel small molecule inhibitor of A2A receptor (A2AR), in a Ph1b study in advanced cancers
McCaffery, I., Laport, G., Hotson, A., Willingham, S., Patnaik, A., Beeram, M., Miller, R.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article